Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1966 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 20.26 USD | +2.37% | +13.44% | +27.50% | +6.91% | 2.14 B USD | ||
| 1967 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.49 USD | +1.66% | -0.06% | +3.84% | +38.22% | 2.12 B USD | ||
| 1977 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 24.31 USD | -0.37% | +1.33% | +38.99% | +115.13% | 2.05 B USD | ||
| 1980 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 23.93 USD | +2.97% | +11.72% | +38.32% | +171.01% | 2.12 B USD | ||
| 1981 |  STOK Stoke Therapeutics, Inc. - Common Stock | 32.99 USD | -0.09% | -1.29% | +12.02% | +170.85% | 2.05 B USD | ||
| 1989 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.77 USD | -1.82% | -2.08% | +13.21% | -30.83% | 2.00 B USD | ||
| 1991 |  SION Sionna Therapeutics, Inc. - Common Stock | 46.37 USD | +3.20% | +9.03% | +42.33% | +17.87% | 2.09 B USD | ||
| 1992 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 18.19 USD | +0.11% | +1.28% | +37.28% | +160.60% | 2.02 B USD | ||
| 2000 |  BCAX Bicara Therapeutics Inc. - Common Stock | 29.99 USD | -1.35% | +0.74% | +47.01% | +107.69% | 1.97 B USD | ||
| 2011 |  NUVB Nuvation Bio Inc. Class A Common Stock | 5.74 USD | +1.23% | +0.88% | +12.99% | +168.22% | 2.00 B USD | ||
| 2015 |  PGEN Precigen, Inc. - Common Stock | 5.67 USD | +2.90% | +1.80% | +54.92% | +225.86% | 2.02 B USD | ||
| 2018 |  ANAB AnaptysBio, Inc. - Common Stock | 67.13 USD | -0.30% | +1.73% | +28.80% | +90.71% | 1.95 B USD | ||
| 2024 |  ZYME Zymeworks Inc. - Common Stock | 26.89 USD | +0.64% | +3.15% | +10.16% | +51.58% | 1.96 B USD | ||
| 2025 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.34 USD | -0.23% | +4.08% | +6.11% | +139.78% | 1.94 B USD | ||
| 2037 |  ATAI AtaiBeckley Inc. - Common Stock | 5.38 USD | +3.66% | +3.86% | +40.47% | +36.20% | 1.98 B USD | ||
| 2044 |  TYRA Tyra Biosciences, Inc. - Common Stock | 32.46 USD | +1.63% | +2.72% | +19.16% | +126.36% | 1.93 B USD | ||
| 2052 |  NBTX Nanobiotix S.A. - ADSs | 38.99 USD | +0.49% | +4.25% | +9.92% | +631.52% | 1.89 B USD | ||
| 2057 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 6.55 USD | +0.77% | -3.39% | +18.87% | +166.26% | 1.88 B USD | ||
| 2061 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 37.65 USD | -0.26% | -0.03% | +34.56% | +98.16% | 1.83 B USD | ||
| 2067 |  MESO Mesoblast Limited - American Depositary Shares | 14.05 USD | -1.68% | +0.07% | -0.99% | +34.97% | 1.80 B USD |
Nouvelles Biotechnology Stocks
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Nurix Therapeutics : les résultats sous l’œil de l’accord avec Roche
L’action Edgewise Therapeutics atteint un sommet historique à 43,96 $
Stifel abaisse la note de Crinetics à Conserver après l’acquisition par Vertex
Gainers Biotechnology Stocks
 APLMW Apollomics Inc. - Warrant | 0.0184 | +53.33% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 PRME Prime Medicine, Inc. - Common Stock | 4.68 | +17.29% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.17 | +13.21% |
 ANVS Annovis Bio, Inc. Common Stock | 2.16 | +11.92% |
 BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.27 | +11.82% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
 ELOX Eloxx Pharmaceuticals, Inc. | 12.01 | +9.68% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0133 | -20.83% |
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.31 | -16.61% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 PHGE BiomX Inc. COmmon Stock | 0.26 | -13.33% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1053 | -11.21% |
 ICUCW SeaStar Medical Holding Corporation - Warrant | 0.0204 | -10.92% |
 ENLV Enlivex Ltd. - Ordinary Shares | 0.44 | -10.20% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.34 | -9.83% |